The reversal of epigenetic silencing of the EBV genome is regulated by viral bZIP protein

Biochemical Society Transactions

Volumn 36, Issue 4, 2008, Pages 637-639

  Karlsson, Questa H ^a   Shelcher, Celine ^a   Verrall, Elizabeth ^a   Petosa, Carlo ^b   Sinclair, Alison J ^a  

^a UNIVERSITY OF SUSSEX   (United Kingdom)

^b EUROPEAN MOLECULAR BIOLOGY LABORATORY   (France)

Author keywords

Basic leucine zipper (bZIP); DNA binding; Epigenetics; Methylation; Transcription factor; Virus

Indexed keywords

BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR; CCAAT ENHANCER BINDING PROTEIN ALPHA; CYSTEINE; IMMEDIATE EARLY PROTEIN BZLF1; SERINE; TRANSCRIPTION FACTOR AP 1; VIRUS DNA;

AMINO ACID SEQUENCE; ARTICLE; B LYMPHOCYTE; BURKITT LYMPHOMA; CHROMATIN ASSEMBLY AND DISASSEMBLY; DNA METHYLATION; EPIGENETICS; EPSTEIN BARR VIRUS; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE SILENCING; HODGKIN DISEASE; HUMAN; INFECTIOUS MONONUCLEOSIS; MOLECULAR MODEL; NASOPHARYNX CARCINOMA; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; SEQUENCE ALIGNMENT; VIRAL GENETICS; VIRUS CARCINOGENESIS; VIRUS GENOME; VIRUS LATENCY; VIRUS PATHOGENESIS; VIRUS REPLICATION;

BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, VIRAL; GENE SILENCING; GENOME, VIRAL; HERPESVIRUS 4, HUMAN; HUMANS; TRANS-ACTIVATORS;

HUMAN HERPESVIRUS 4;

EID: 49349094196     PISSN: 03005127     EISSN: None     Source Type: Journal    
DOI: 10.1042/BST0360637     Document Type: Article

References (32)

1. Young, L.S. and Rickinson, A.B. (2004) Epstein-Barr virus: 40 years on. Nat. Rev. Cancer 4, 757-768
2. Bornkamm, G.W. and Hammerschmidt, W. (2001) Molecular virology of Epstein-Bair virus, Philos. Trans. R. Soc. London Ser. B 356, 437-459
3. Young, L.S. and Murray, P.G. (2003) Epstein-Barr virus and oncogenesis: from latent genes to tumours. Oncogene 22, 5108-5121
4. Murray, P.G. and Young, L.S. (2001) Epstein-Barr virus infection: basis of malignancy and potential for therapy. Expert Rev. Mol. Med. 2001, 1-20
5. Thorley-Lawson, D.A. and Babcock, G.J. (1999) A model for persistent infection with Epstein-Barr virus: the stealth virus of human B cells. Life Sci. 65, 1433-1453
6. Minarovits, J. (2006) Epigenotypes of latent herpesvirus genomes. Curr. Top. Microbiol. Immunol. 310, 61-80
7. Gyory, I. and Minarovits, J. (2005) Epigenetic regulation of lymphoid specific gene sets. Biochem. Cell Biol. 83, 286-295
8. Li, H.P., Leu, Y.W. and Chang, Y.S. (2005) Epigenetic changes in virus-associated human cancers. Cell Res. 15, 262-271
9. Li, H. and Minarovits, J. (2003) Host celldependent expression of latent Epstein-Barr virus genomes: regulation by DNA methylation. Adv. Cancer Res. 89, 133-156
10. Tao, Q. and Robertson, K.D. (2003) Stealth technology: how Epstein-Barr virus utilizes DNA methylation to cloak itself from immune detection. Clin. Immunol. 109, 53-63
11. Lo, K.W. and Huang, D.P. (2002) Genetic and epigenetic changes in nasopharyngeal carcinoma. Semin. Cancer Biol. 12, 451-462
12. Lindstrom, M.S. and Wiman, K.G. (2002) Role of genetic and epigenetic changes in Burkitt lymphoma. Semin. Cancer Biol. 12, 381-387
13. Robertson, K.D. (2000) The role of DNA methylation in modulating Epstein-Barr virus gene expression. Curr. Top. Microbiol. Immunol. 249, 21-34
14. Ambinder, R.F., Robertson, K.D. and Tao, Q. (1999) DNA methylation and the Epstein-Barr virus. Semin. Cancer Biol. 9, 369-375
15. Klose, R.J. and Bird, A.P. (2006) Genomic DNA methylation: the mark and its mediators. Trends Biochem. Sci. 31, 89-97
16. Watt, F. and Molloy, P.L. (1988) Cytosine methylation prevents binding to DNA of a HeLa cell transcription factor required for optimal expression of the adenovirus major late promoter. Genes Dev. 2, 1136-1143
17. Sinclair, A.J. (2006) Unexpected structure of Epstein-Barr virus lytic cycle activator Zta. Trends Microbiol. 14, 289-291
18. Sinclair, A.J. (2003) bZIP proteins of human gammaherpesviruses. J. Gen. Virol. 84, 1941-1949
19. Sinclair, A.J. and Farrell, P.J. (1992) Epstein-Barr virus transcription factors. Cell Growth Differ. 3, 557-563
20. Morand, P., Budayova-Spano, M., Perrissin, M., Muller, C.W. and Petosa, C. (2006) Expression, purification, crystallization and preliminary X-ray analysis of a C-terminal fragment of the Epstein-Barr virus ZEBRA protein. Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 62, 210-214
21. Petosa, C., Morand, P., Baudin, F., Moulin, M., Artero, J.B. and Muller, C.W. (2006) Structural basis of lytic cycle activation by the Epstein-Barr virus ZEBRA protein. Mol. Cell 21, 565-572
22. Schelcher, C., Al Mehairi, S., Verrall, E., Hope, Q., Flower, K., Bromley, B., Woolfson, D.N., West, M.J. and Sinclair, A.J. (2007) Atypical bZIP domain of viral transcription factor contributes to stability of dimer formation and transcriptional function. J. Virol. 81, 7149-7155
23. Hicks, M.R., Balesaria, S., Medina-Palazon, C., Pandya, M.J., Woolfson, D.N. and Sinclair, A.J. (2001) Biophysical analysis of natural variants of the multimerization region of Epstein-Barr virus lytic-switch protein BZLF1. J. Virol. 75, 5381-5384
24. Hicks, M.R., Al-Mehairi, S.S. and Sinclair, AJ. (2003) The zipper region of Epstein-Barr virus bZIP transcription factor Zta is necessary but not sufficient to direct DNA binding. J. Virol. 77, 8173-8177
25. Sinclair, A.J., Brimmell, M., Shanahan, F. and Farrell, P.J. (1991) Pathways of activation of the Epstein-Barr virus productive cycle, J. Virol. 65, 2237-2244
26. Feederle, R., Kost, M., Baumann, M., Janz, A., Drouet, E., Hammerschmidt, W. and Delecluse, H.J. (2000) The Epstein-Barr virus lytic program is controlled by the co-operative functions of two tfansactivators. EMBO J. 19, 3080-3039
27. Morand, P., Budayova-Spano, M., Perrissin, M., Muller, C.W. and Petosa, C (2006) Expression, purification, crystallization and preliminary X-ray analysis of a C-terminal fragment of the Epstein-Barr virus ZEBRA protein. Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 62, 210-214
28. Bhende, P.M., Seaman, W.T., Delecluse, H.J. and Kenney, S.C. (2004) The EBV lytic switch protein, Z, preferentially binds to and activates the methylated viral genome. Nat. Genet. 36, 1099-1104
29. Bhende, P.M., Seaman, W.T., Delecluse, H.J. and Kenney, S.C. (2005) BZLF1 activation of the methylated form of the BRLF1 immediate-early promoter is regulated by BZLF1 residue 186. J. Virol. 79, 7338-7348
30. Wang, P., Day, L., Dheekollu, J. and Lieberman, P.M. (2005) A redox-sensitive cysteine in Zta is required for Epstein-Barr virus lytic cycle DNA replication. J. Virol. 79, 13298-13309
31. Karlsson, Q.H., Schelcher, C., Verrall, E., Petosa, C. and Sinclair, A.J. (2008) Methylated DNA recognition during the reversal of epigenetic silencing is regulated by cysteine and serine residues in the Epstein-Barr virus lytic switch protein. PLoS Pathog. 4, e1000005
32. Schelcher, C., Valencia, S., Delecluse, H.J., Hicks, M. and Sinclair, A.J. (2005) Mutation of a single amino acid residue in the basic region of the Epstein-Barr virus (EBV) lytic cycle switch protein Zta (BZLF1) prevents reactivation of EBV from latency. J. Virol. 79, 13822-13828